INTRODUCTION
Stroke (focal cerebral injury with an underlying vascular basis) is typically classified into ischemic or hemorrhagic subtypes. Ischemic stroke (IS) is further subdivided into arterial ischemic stroke (AIS) and cerebral sinovenous thrombosis (CSVT). Stroke is increasingly recognized as a serious neurologic disorders of children and awareness about pediatric stoke is increasing. In western countries, the incidence of pediatric AIS is estimated at 2-3/100000 children/year during the first 5 years and 8-13/100000 from 5 to 14 years 8) . Many cases occur during the perinatal or neonatal period, during which the incidence is approximately 1/4000 live birth 14) . Stroke is also commonly encountered disease in the practice of pediatric neurology and among the top 10 causes of death in children, with highest rates in the 1st year of life in USA 2) . Therefore, the timely appropriate diagnosis and detection of associated risk factors is very important to improve the management and modify the prognosis. However, even when stroke presents acutely, delays in diagnosis are common and appropriate treatments are difficult because pediatric stroke is relatively rare and the etiologies and associated risk factors are remarkably variable depending on ages and different from those of adults. The International Pediatric Stroke Study (IPSS) and other studies of childhood stroke reported various underlying systemic factors associated with pediatric stroke. In previous studies, preexisting risk factors have been reported in 77-79% of childhood stroke and common both in ischemic and hemorrhagic stroke, compared to adult. They occur in up to 50% of children, which are not restricted to any age group 24) . In addition to focal neurologic deficits, non-focal and diffuse neurologic symptoms such as headache, confusion, irritability and behavioral changes are frequent especially in younger children 5, 13, 23) . Clinical presentation can be significantly different based on the child' s age. The younger the child, more non-specific for their symptoms. Neonates usually present with seizures and symptoms of encephalopathy (irritability, lethargy, excessive sleeps, or poor feeding) or apnea. Focal neurologic deficits occur in less than 25% of all newborns. Toddlers can also present with nonspecific symptoms such as increased crying, drowsiness, irritability, poor feeding, vomiting and sepsis-like features. With increasing ages, stroke manifests with a clinical presentation similar to that in adults. The other typical presentation in children is fluctuation course of neurologic deficits, which are frequently brief/recurrent and may resolve as quickly as within a few hours. This should alert the clinician to the possibility of an underlying vasculopathy or thromboembolic causes.
There are many other diseases, which may mimic a stroke. Complicated migraine can cause focal neurologic deficits which typically resolve within 24 hours and usually having family history of hemiplegic migraine 23) . Partial seizures can result in transient postictal paresis (Todd' s palsy). Brain tumor as well as intracranial infection such as meningitis, encephalitis, and brain abscess are also considered as a differential diagnosis. Rarely alternating hemiplegia, metabolic disorders like Mitochondrial Encephalopathy, Lactic Acidosis and Stroke like episodes (MELAS) can also cause stroke like symptoms.
ETIOLOGIES/RISK FACTORS
Etiologies/risk factors in childhood stroke differ from those in adult stroke 11) . The etiologies/risk factors identified in adult cases are primarily related to arrhythmias and obstructive atherosclerotic arteriopathies; in contrast, these are rarely thought to be related to childhood stroke. The International Pediatric Stroke Study (IPSS) and other studies of childhood stroke reported various underlying systemic factors. Approximately 50-80% children with AIS have at least one identifiable risk factor for stroke and multiple risk factors often present in as many a 25% of children with stroke 3, 7, 11) . According to the largest study by the IPSS of 493 children with stroke in 10 countries, risk factor variability can be influenced by geography, ethnicity, age at presentation and the availability of medical resources 11) . In neonatal stroke, dehydration, infection and congenital heart disease are more commonly associated compared to older children 13) . Arteriopathies and congenital heart disease (CHD) are commonly associated from 20-50% of AIS in children in developed countries 1, 10) . Studies in Saudi Arabia and Northern India reported infectious etiologies to be the most common risk factor for stroke in tertiary centers, with similar findings in Beijing, China, and Turkey. In referral centers located in areas with a large African or Mediterranean population, hemoglobinopathies including sickle cell disease (SCD) may be the most common cause 15, [17] [18] [19] [20] . In East Asian countries, MMD is the most common etiologies in pediatric stroke 9) . Inherited metabolic diseases such as mitochondrial encephalopathies, Fabrys disease, Menke's disease, organic academia, urea cycle defects and homocystinuia can result in acute focal neurological deficits and stroke-like episodes. In cases of radiological evidence of infarction that is not confined to a known vascular territory, metabolic causes may be a consideration 6, 21, 22) . For assessment of etiologies and risk factors, there are no clearly established guidelines in pediatric stroke. Laboratory assessment including a variety of nonspecific blood tests and more specific tests searching for specific causes of stroke, such as coagulopathies, hematologic disorders or vasculitides are suggested (Table 2) .
DATA FROM TERTIARY CENTERS IN KOREA
We reviewed our cohort of 185 patients with pediatric stroke, 4) deVeber et al. 3) Earley et al. 4) Meyer-Heim and Boltshauser Stroke was classified into AIS, CSVT, metabolic stroke (MS), and hemorrhagic stroke. MS results from energy failure caused by metabolic conditions such as mitochondrial disease, organic acidemias, and single-gene diseases. Risk factors for AIS were subdivided into four groups : arteriopathy, cardiac disease, prothrombotic condition, and hematologic disease.
Among 185 patients, male dominance was more prominent in adolescence (sex ratio, 3.5 : 1) than it was in preadolescence. The mean age at diagnosis was 6.5 years.
Most patients (n=149, 81%) had two of more symptoms at onset. One hundred seventy-four patients (94%) presented with focal neurological signs : paresis (n=132, 71%), seizure (n=71, 38%), speech impairment, paresthesia, and other focal neurological deficits. Diffuse signs were documented in 102 patients (55%) : headache (n=50, 27%), altered mentality (n=34, 18%), lethargy, nausea/vomiting, dizziness, and other diffuse signs. Ninety-one patients (49%) had both focal and diffuse signs (mixed signs).
There were 156 (156/185, 84.3%) patients with AIS, nine patients with CSVT, nine patients with MS, and 11 patients with HS. Presumptive risk factors were identified in 154 patients (83%).
In AIS, most common risk factors were arteriopathy, followed by cardiac disease, prothrombotic condition, and hematologic disease. Arteriopathy (n=83) includes MMD; CNS infection; inflammatory vasculopathy; systemic vasculitis; arterial dissection; other noninflammatory vasculopathies. Twenty-three patients had underlying cardiac diseases; congenital heart disease, infective endocarditis, arrhythmia, myocarditis, cardiomyopathy, and left atrial myxoma. Prothrombotic condition (n=14) includes methylenetetrahydrofolate reductase (MTHFR) gene mutation, antiphospholipid syndrome (APS) and chemotherapy. Hematologic disorders were detected on a single case basis in six patients; leukemia, iron-deficiency anemia, hemophagocytic lymphohistiocytosis, hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and suprasellar craniopharyngioma. CSVT was identified in nine patients : severe dehydration (n=3); infection (n=3); prothrombotic condition (n=3) such as APS, MTHFR gene mutation, and L-asparaginase. Nine patients were newly diagnosed as having mitochondrial disease : eight patients had mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS), and were confirmed to have the mitochondrial DNA 3243 point mutation. Hemorrhagic stroke affected 11 patients. There were arteriovenous malformation, MMD, arterial aneurysm, arterial dissection, mycotic embolism, MTHFR gene mutation, and Evans syndrome. Table 3 summarizes the risk factor by stroke types, including previous publication by Lee et al. 9) . The most common single etiology was MMD in both centers.
The most common etiology/risk factors are different according to ages in pediatric stroke. Stroke in children under 1 year of age is more likely to be associated with CNS infection, whereas older children were more likely to have vascular diseases in- (Table 4) .
CONCLUSION
Pediatric stroke is an importance cause of disability and mortality. However, since the incidence is still low, risk factors are variable according to ethnic groups and ages and etiologies are different, the symptoms are more non-specific compare to adults, it remains a challenge to early diagnosis and appropriate management.
Therefore, high suspicion is important for pediatric neurologists and early recognition, diagnosis, and appropriate treatment based on etiologies/risk factor can significantly improve the clinical outcome and quality of life. 
